These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 31499054)
1. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy. Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054 [TBL] [Abstract][Full Text] [Related]
2. Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy. Zhao T; Zhang H; Zhang X; Zhao T; Lan HY; Liang Q; Luo G; Li P J Ethnopharmacol; 2015 May; 166():31-41. PubMed ID: 25698246 [TBL] [Abstract][Full Text] [Related]
3. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy. Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720 [TBL] [Abstract][Full Text] [Related]
4. Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy. Zhang Q; Ye Q; Huang X; Xu A; Liu Y; Qi J; Zhang H; Zhang J BMC Complement Med Ther; 2020 Nov; 20(1):362. PubMed ID: 33228635 [TBL] [Abstract][Full Text] [Related]
5. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling. Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395 [TBL] [Abstract][Full Text] [Related]
6. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS]. Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524 [TBL] [Abstract][Full Text] [Related]
7. Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway. Zhang Y; Yao H; Li C; Sun W; Chen X; Cao Y; Liu Y; Liu Y; Chen J; Qi J; Zhang Q; Zhang H; Xu A; Zhang J Oxid Med Cell Longev; 2022; 2022():6275505. PubMed ID: 35480869 [TBL] [Abstract][Full Text] [Related]
8. [Effect of compatibility of Corni Fructus before and after wine-processing with Astragali Radix on plasma metabolomics in diabetic nephropathy rats based on UHPLC-Q-TOF-MS/MS]. Chen YJ; Zhu H; Liu X; Duan Y; Pei K; Zhang Q; Song PX; Cai H Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3493-3504. PubMed ID: 39041121 [TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862 [TBL] [Abstract][Full Text] [Related]
10. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats. Ge J; Miao JJ; Sun XY; Yu JY J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243 [TBL] [Abstract][Full Text] [Related]
11. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry. Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279 [TBL] [Abstract][Full Text] [Related]
12. Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using UPLC-Q-TOF-MS combined with pattern recognition. Gong P; Chang X; Chen X; Bai X; Wen H; Pi S; Yang W; Wang L; Chen F Environ Toxicol Pharmacol; 2017 Sep; 54():80-92. PubMed ID: 28704754 [TBL] [Abstract][Full Text] [Related]
13. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice. Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154 [TBL] [Abstract][Full Text] [Related]
15. Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy. Sun GD; Li CY; Cui WP; Guo QY; Dong CQ; Zou HB; Liu SJ; Dong WP; Miao LN J Diabetes Res; 2016; 2016():5749857. PubMed ID: 26649322 [TBL] [Abstract][Full Text] [Related]
16. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
17. Effects of Bailing capsule on diabetic nephropathy based on UPLC-MS urine metabolomics. Xu J; Yuan Q; Wu K; Li X; Zhao Y; Li X RSC Adv; 2019 Nov; 9(62):35969-35975. PubMed ID: 35540588 [TBL] [Abstract][Full Text] [Related]
18. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Zhu C; Liang QL; Hu P; Wang YM; Luo GA Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats. Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792 [TBL] [Abstract][Full Text] [Related]
20. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies. Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]